×
Hero Background

Plasma Therapy Companies

ID: MRFR/HC/9249-HCR
200 Pages
Rahul Gotadki
October 2025

Plasma therapy, also known as convalescent plasma therapy, involves using the plasma from individuals who have recovered from a specific infection to treat others. This therapeutic approach has been explored for various infectious diseases, including viral infections.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Plasma Therapy Market Research Report—Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Plasma Therapy Market

Plasma Therapy Key Companies

 


Latest Plasma Therapy Companies Update:

Octapharma


January 22, 2024: Published data from the WIL-31 study, marking a milestone in improving long-term care for severe von Willebrand disease (VWD) patients.January 9, 2024: Announced availability of Balfaxar® for warfarin reversal in urgent surgery and invasive procedures.


CSL (Australia)


April 2023: Received FDA approval for a new prefilled syringe of Hizentra for patients with primary immunodeficiency (PI) and chronic inflammatory demyelinating polyneuropathy (CIPD).


Grifols (Spain)


March 2022 Received European approvals for XEMBIFY, a 20% subcutaneous immunoglobulin (SCIG) for PI treatment.


List of Plasma Therapy Key companies in the market

  • BioLife Plasma Services (US)

  • Cambryn Biologics LLC (US)

  • Biotest (Germany)

  • CSL Ltd. (Australia)

  • Grifols International S.A. (Spain)

  • Kedrion S.p.A. (Italy)

  • LFB S.A (France)

  • Bio Products Laboratory Ltd. (U.K.)

  • China Biologic Products, Inc. (China)

  • Octapharma (Switzerland)

  • Arthrex, Inc. (US)

  • DePuy Synthes Companies (US)

  • Grifols S.A (Spain)

  • Global Stem Cells Group, Inc. (US)

  • Juventix Regenerative Medical LLC (U.S.)

  • Celling Biosciences, Inc. (U.S.)